EUVIMEDSkopri EUVIMED
Crossref

Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus

Zahra Javanmardi, Mahmoud Mahmoudi, Houshang Rafatpanah, Zahra Rezaieyazdi, Abbas Shapouri-Moghaddam, Parisa Ahmadi, Samaneh Mollazadeh, Nafiseh Sadat Tabasi, Seyed-Alireza Esmaeili

Cell Biochemistry and Function · 2024

DOI: 10.1002/cbf.3981 ↗

At a glance

Journal article in Cell Biochemistry and Function, 2024. Written by Zahra Javanmardi and 8 co-authors. Institution: Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Major MEDLINE topics: Lacticaseibacillus rhamnosus, Lactobacillus delbrueckii, Lupus Erythematosus, Systemic, Probiotics. Cited 17 times so far (Crossref); 89 references. Funded by: Mashhad University of Medical Sciences.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Systemic lupus erythematosus (SLE) is known as an autoimmune disorder that is characterized by the breakdown of self‐tolerance, resulting in disease onset and progression. Macrophages have been implicated as a factor in the development of SLE through faulty phagocytosis of dead cells or an imbalanced M1/M2 ratio. The study aimed to investigate the immunomodulatory effects of Lactobacillus delbrueckii and Lactobacillus rhamnosus on M1 and M2 macrophages in new case lupus patients. For this purpose, blood monocytes were collected from lupus patients and healthy people and were cultured for 5 days to produce macrophages. For 48 h, the macrophages were then cocultured with either probiotics or lipopolysaccharides (LPS). Flow cytometry and real‐time polymerase chain reaction were then used to analyze the expression of cluster of differentiation (CD) 14, CD80, and human leukocyte antigen – DR (HLADR) markers, as well as cytokine expression (interleukin [IL]1‐β, IL‐12, tumor necrosis factor α [TNF‐α], IL‐10, and transforming growth factor beta [TGF‐β]). The results indicated three distinct macrophage populations, M0, M1, and M2. In both control and patient‐derived macrophage‐derived monocytes (MDMs), the probiotic groups showed a decrease in CD14, CD80, and HLADR expression compared to the LPS group. This decrease was particularly evident in M0 and M2 macrophages from lupus patients and M1 macrophages from healthy subjects. In addition, the probiotic groups showed increased levels of IL‐10 and TGF‐β and decreased levels of IL‐12, IL1‐β, and TNF‐α in MDMs from both healthy and lupus subjects compared to the LPS groups. Although there was a higher expression of pro‐inflammatory cytokines in lupus patients, there was a higher expression of anti‐inflammatory cytokines in healthy subjects. In general, L. delbrueckii and L. rhamnosus could induce anti‐inflammatory effects on MDMs from both healthy and lupus subjects.

Subjects

MeSH terms (MEDLINE)

Lacticaseibacillus rhamnosusLactobacillus delbrueckiiLupus Erythematosus, SystemicProbioticsHumansMonocytesInterleukin-10Tumor Necrosis Factor-alphaLipopolysaccharidesMacrophagesCytokinesAnti-Inflammatory AgentsInterleukin-12Transforming Growth Factor beta

Author keywords

Lactobacillus delbrueckiiLactobacillus rhamnosusM0/M1/M2 macrophagesmacrophageprobioticsystemic lupus erythematosus

Substances

Interleukin-10Tumor Necrosis Factor-alphaLipopolysaccharidesCytokinesAnti-Inflammatory AgentsInterleukin-12Transforming Growth Factor beta

Authors and institutions

  • Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Immunology Research Centre, Division of Inflammation and Inflammatory Diseases, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.

Funding

  • Mashhad University of Medical Sciences

Cite

APA

Javanmardi, Z., Mahmoudi, M., Rafatpanah, H., Rezaieyazdi, Z., Shapouri-Moghaddam, A., Ahmadi, P., Mollazadeh, S., Tabasi, N. S., & Esmaeili, S. A. (2024). Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3981

Vancouver

Javanmardi Z, Mahmoudi M, Rafatpanah H, Rezaieyazdi Z, Shapouri-Moghaddam A, Ahmadi P, et al. Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.3981

BibTeX
@article{Javanmardi2024,
  author = {Javanmardi, Zahra and Mahmoudi, Mahmoud and Rafatpanah, Houshang and Rezaieyazdi, Zahra and Shapouri-Moghaddam, Abbas and Ahmadi, Parisa and Mollazadeh, Samaneh and Tabasi, Nafiseh Sadat and Esmaeili, Seyed-Alireza},
  title = {Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  doi = {10.1002/cbf.3981}
}
Start for free →